320 related articles for article (PubMed ID: 26478275)
1. Applying a novel electrostatic dry powder coating technology to pellets.
Yang Q; Ma Y; Zhu J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
[TBL] [Abstract][Full Text] [Related]
2. A novel electrostatic dry powder coating process for pharmaceutical dosage forms: immediate release coatings for tablets.
Qiao M; Zhang L; Ma Y; Zhu J; Chow K
Eur J Pharm Biopharm; 2010 Oct; 76(2):304-10. PubMed ID: 20600889
[TBL] [Abstract][Full Text] [Related]
3. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the film formation of the dry coating process.
Kablitz CD; Urbanetz NA
Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
[TBL] [Abstract][Full Text] [Related]
5. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
[TBL] [Abstract][Full Text] [Related]
6. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
7. Dry powder coating of pellets with micronized Eudragit RS for extended drug release.
Pearnchob N; Bodmeier R
Pharm Res; 2003 Dec; 20(12):1970-6. PubMed ID: 14725361
[TBL] [Abstract][Full Text] [Related]
8. A novel approach for dry powder coating of pellets with Ethylcellulose. Part I: Evaluation of film formulation and process set up.
Albertini B; Bertoni S; Melegari C; Dolci LS; Passerini N
Int J Pharm; 2017 Jan; 516(1-2):380-391. PubMed ID: 27894987
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the drug release and surface morphological properties of film-coated pellets, and physical, thermal and mechanical properties of free films as a function of various curing conditions.
Bhattacharjya S; Wurster DE
AAPS PharmSciTech; 2008; 9(2):449-57. PubMed ID: 18431665
[TBL] [Abstract][Full Text] [Related]
10. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
Terebesi I; Bodmeier R
Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
[TBL] [Abstract][Full Text] [Related]
11. High efficiency dry coating of non-subcoated pellets for sustained drug release formulations using amino methacrylate copolymers.
Klar F; Urbanetz NA
Pharm Dev Technol; 2018 Dec; 23(10):1088-1096. PubMed ID: 29192521
[TBL] [Abstract][Full Text] [Related]
12. Coating of pellets with micronized ethylcellulose particles by a dry powder coating technique.
Pearnchob N; Bodmeier R
Int J Pharm; 2003 Dec; 268(1-2):1-11. PubMed ID: 14643971
[TBL] [Abstract][Full Text] [Related]
13. A Novel Approach for Dry Powder Coating of Pellets with Ethylcellulose. Part II: Evaluation of Caffeine Release.
Albertini B; Melegari C; Bertoni S; Dolci LS; Passerini N
AAPS PharmSciTech; 2018 Apr; 19(3):1426-1436. PubMed ID: 29441468
[TBL] [Abstract][Full Text] [Related]
14. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
Zhu Y; Mehta KA; McGinity JW
Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
16. Electrostatic powder coating: Principles and pharmaceutical applications.
Prasad LK; McGinity JW; Williams RO
Int J Pharm; 2016 May; 505(1-2):289-302. PubMed ID: 27085644
[TBL] [Abstract][Full Text] [Related]
17. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
Cerea M; Zheng W; Young CR; McGinity JW
Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
[TBL] [Abstract][Full Text] [Related]
18. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
19. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
Sauer D; McGinity JW
Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
[TBL] [Abstract][Full Text] [Related]
20. Dry powder coating of pharmaceuticals: a review.
Sauer D; Cerea M; DiNunzio J; McGinity J
Int J Pharm; 2013 Dec; 457(2):488-502. PubMed ID: 23428881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
